1 |
Yonemoto N, Furuse J, Okusaka T, et al (2007). A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol, 37, 843-51.
DOI
ScienceOn
|
2 |
Baier M, Bannert N, Werner A, et al (1997). Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A, 94, 5273-7.
DOI
|
3 |
Batai K, Shah E, Murphy AB, et al (2012). Fine-mapping of IL16 gene and prostate cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev, 21, 2059-68.
DOI
|
4 |
Chung YC, Chang YF (2003). Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol, 83, 222-6.
DOI
ScienceOn
|
5 |
Drwinga HL, Toji LH, Kim CH, et al (1993). NIGMS human/ rodent somatic cell hybrid mapping panels 1 and 2. Genomics, 16, 311-4.
DOI
ScienceOn
|
6 |
Gao LB, Liang WB, Xue H, et al (2009b). Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta, 409, 132-5.
DOI
ScienceOn
|
7 |
Graham DY, Adam E, Reddy GT, et al (1991). Seroepidemiology of Helicobacter pylori infection in India; comparison of developing and developing countries. Dig Dis Sci, 36, 1084-8.
DOI
|
8 |
Gao LB, Rao L, Wang YY, et al (2009a). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis, 30, 295-9.
|
9 |
Ghoshal UC, Tiwari S, Dhingra S, et al (2008). Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasm and controls: the Indian enigma. Dig Dis Sci, 53, 1215-22.
DOI
|
10 |
Ghoshal UC, Tripathi S, Ghoshal U (2007). The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host's genetic make up, or friendly bug? Am J Gastroenterol, 102, 2113-4.
DOI
ScienceOn
|
11 |
Gu XJ, Cui B, Zhao ZF, et al (2008). Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. Clin Immunol, 127, 298-302.
DOI
ScienceOn
|
12 |
Huang H, Zeng Z, Zhang L, et al (2013). The association of interleukin-16 gene polymorphisms with susceptibility of coronary artery disease. Clin Biochem, 46, 241-4.
DOI
ScienceOn
|
13 |
International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC.
|
14 |
Kai H, Kitadai Y, Kodama M, et al (2005). Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res, 25, 709-13.
|
15 |
Liebrich M, Guo LH, Schluesener HJ, et al (2007). Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp (Warsz), 55, 41-7.
DOI
|
16 |
Milke L, Schulz K, Weigert A, et al (2013). Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/ macrophages. Carcinogenesis, 34, 850-7.
DOI
ScienceOn
|
17 |
Li S, Deng Y, Chen ZP, et al (2011). Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol, 11, 2083-8.
DOI
ScienceOn
|
18 |
Mahindra A, Anderson KC (2012). Role of interleukin 16 in multiple myeloma pathogenesis: a potential novel therapeutic target? J Natl Cancer Inst, 104, 964-5.
DOI
ScienceOn
|
19 |
Nakayama EE, Wasi C, Ajisawa A, et al (2000). A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun, 1, 293-4.
DOI
ScienceOn
|
20 |
Mathy NL, Scheuer W, Lanzendorfer M, et al (2000). Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 100, 63-9.
DOI
|
21 |
Ni P, Xu H, Xue H, et al (2012). A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol, 31, 582-91.
DOI
ScienceOn
|
22 |
Parsonnet J, Friedman GD, Orentreich N, et al (1997). Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40, 297-301.
DOI
|
23 |
Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A (2007). Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev, 18, 171-82.
DOI
ScienceOn
|
24 |
Schneider MR, Hoeflich A, Fischer JR, et al (2000). Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett, 151, 31-8.
DOI
ScienceOn
|
25 |
Shanmugham LN, Petrarca C, Frydas S, et al (2006). IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. J Exp Clin Cancer Res, 25, 529-36.
|
26 |
Thomas G, Jacobs KB, Yeager M, et al (2008). Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet, 40, 310-5.
DOI
ScienceOn
|
27 |
Wu J, Wang Y, Zhang Y, Li L (2011). Association between interleukin-16 polymorphisms and risk of coronary artery disease. DNA Cell Biol, 30, 305-8.
DOI
ScienceOn
|
28 |
Zhang Y, Center DM, Wu DM, et al (1998). Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem, 273, 1144-9.
DOI
ScienceOn
|
29 |
Yellapa A, Bahr JM, Bitterman P, et al (2012). Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer. Int J Gynecol Cancer, 22, 199-207.
DOI
ScienceOn
|
30 |
Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36.
DOI
ScienceOn
|
31 |
Xue H, Lin B, An J, et al (2012). Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer, 12, 102.
DOI
|